VAERS reports by lot

Moderna COVID-19 lot 006021A: VAERS reports

38 VAERS reports list lot 006021A as a Moderna COVID-19 vaccine, received between 2021-05-07 and 2022-06-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
38
Reports
5%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4223%
Cardiac / Cardiovascular2614%
Musculoskeletal2212%
Neurological2112%
Injection-site / Local reaction1910%
Respiratory148%
Gastrointestinal116%
Allergic / Anaphylactic105%
Dermatological (non-injection-site)74%
Thrombotic / Hematological63%
Psychiatric / Neuropsychiatric42%

Where reports came from

U.S. state of the reporter, where given (top 12).

Georgia4
Indiana4
Pennsylvania3
California3
Mississippi3
Texas2
Missouri2
Arizona2
Michigan2
Kentucky1
Nevada1
South Carolina1

Reports by month received

2021-051
2021-061
2021-072
2021-084
2021-099
2021-106
2021-117
2021-123
2022-013
2022-031
2022-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.